Patent · US Active

Pyrimidine nucleosides and their monophosphate prodrugs for the treatment of viral infections and cancer

US9809616B2 · kind B2 · utility

13Cited by

2References

11Claims

0Family size

Assignees

EMORY UNIVERSITY · US
COCRYSTAL PHARMA, INC. · US

Inventors

Franck Amblard · Tucker, US
Steven J. Coats · McDonough, US
Raymond F. Schinazi · Decatur, US

Key dates

Filing date	Oct 29, 2013
Grant date	Nov 7, 2017
Priority date	—
Expiry date	Oct 29, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07H19/11
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The compounds are of the class of N4-hydroxycytidine nucleosides, modified monophosphate and phosphonates prodrugs analogs, and pharmaceutically acceptable, salts, prodrugs, and other derivatives thereof, useful in treating HCV or Norovirus infections.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.